Harmony Biosciences to Participate in Annual Healthcare Conference

The pharmaceutical company will present at the 25th Needham Virtual Healthcare Conference.

Mar. 31, 2026 at 2:44pm

A minimalist, glowing neon outline of a sleeping person's silhouette against a dark background, conceptually representing the sleep disorders that Harmony Biosciences aims to treat.Harmony Biosciences showcases its sleep disorder treatments at a major healthcare industry conference.Plymouth Meeting Today

Harmony Biosciences, a pharmaceutical company focused on sleep disorders and rare neurological conditions, announced that it will participate in the 25th Annual Needham Virtual Healthcare Conference. The conference is scheduled to take place on March 31, 2026.

Why it matters

Harmony Biosciences' participation in this high-profile healthcare industry event signals the company's continued growth and commitment to advancing treatments for sleep disorders and rare neurological conditions. The conference provides an opportunity for the company to showcase its pipeline and engage with industry stakeholders.

The details

As part of the conference, Harmony Biosciences will present an overview of the company's business and clinical development programs. The presentation will be available via a live webcast and a replay will be accessible on the company's website following the event.

  • The 25th Annual Needham Virtual Healthcare Conference is scheduled for March 31, 2026.

The players

Harmony Biosciences

A pharmaceutical company focused on developing treatments for sleep disorders and rare neurological conditions.

Got photos? Submit your photos here. ›

What’s next

Investors and other interested parties will be able to access the webcast and replay of Harmony Biosciences' presentation on the company's website following the conference.

The takeaway

Harmony Biosciences' participation in the prestigious Needham Virtual Healthcare Conference underscores the company's growing prominence in the pharmaceutical industry and its commitment to advancing innovative treatments for sleep disorders and rare neurological conditions.